News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
736,422 Results
Type
Article (44959)
Company Profile (477)
Press Release (690977)
Multimedia
Podcasts (111)
Webinars (20)
Section
Business (210328)
Career Advice (2235)
Deals (36254)
Drug Delivery (113)
Drug Development (84270)
Employer Resources (177)
FDA (16711)
Job Trends (15326)
News (355990)
Policy (33592)
Tag
Academia (2693)
Accelerated approval (18)
Adcomms (31)
Allergies (124)
Alliances (51428)
ALS (143)
Alzheimer's disease (1624)
Antibody-drug conjugate (ADC) (247)
Approvals (16792)
Artificial intelligence (435)
Autoimmune disease (97)
Automation (30)
Bankruptcy (375)
Best Places to Work (11906)
BIOSECURE Act (21)
Biosimilars (157)
Biotechnology (332)
Bladder cancer (137)
Brain cancer (49)
Breast cancer (510)
Cancer (4027)
Cardiovascular disease (337)
Career advice (1879)
Career pathing (34)
CAR-T (243)
CDC (44)
Cell therapy (655)
Cervical cancer (31)
Clinical research (70481)
Collaboration (1398)
Company closure (4)
Compensation (956)
Complete response letters (52)
COVID-19 (2778)
CRISPR (83)
C-suite (606)
Cystic fibrosis (139)
Data (4904)
Decentralized trials (2)
Denatured (35)
Depression (107)
Diabetes (438)
Diagnostics (6647)
Digital health (35)
Diversity (11)
Diversity, equity & inclusion (46)
Drug discovery (203)
Drug pricing (171)
Drug shortages (29)
Duchenne muscular dystrophy (207)
Earnings (90733)
Editorial (52)
Employer branding (21)
Employer resources (154)
Events (119956)
Executive appointments (961)
FDA (19233)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (6)
Frontotemporal dementia (16)
Funding (1260)
Gene editing (176)
Generative AI (33)
Gene therapy (533)
GLP-1 (944)
Government (4794)
Grass and pollen (7)
Guidances (372)
Healthcare (19389)
HIV (45)
Huntington's disease (39)
IgA nephropathy (66)
Immunology and inflammation (234)
Immuno-oncology (20)
Indications (60)
Infectious disease (3010)
Inflammatory bowel disease (183)
Inflation Reduction Act (16)
Influenza (96)
Intellectual property (198)
Interviews (360)
IPO (16938)
IRA (51)
Job creations (3802)
Job search strategy (1575)
Kidney cancer (15)
Labor market (75)
Layoffs (574)
Leadership (30)
Legal (8138)
Liver cancer (88)
Longevity (11)
Lung cancer (576)
Lymphoma (282)
Machine learning (31)
Management (60)
Manufacturing (626)
MASH (142)
Medical device (13846)
Medtech (13872)
Mergers & acquisitions (20212)
Metabolic disorders (1117)
Multiple sclerosis (136)
NASH (21)
Neurodegenerative disease (221)
Neuropsychiatric disorders (58)
Neuroscience (2655)
NextGen: Class of 2025 (6858)
Non-profit (4636)
Now hiring (59)
Obesity (533)
Opinion (266)
Ovarian cancer (141)
Pain (160)
Pancreatic cancer (175)
Parkinson's disease (237)
Partnered (29)
Patents (416)
Patient recruitment (332)
Peanut (53)
People (60053)
Pharmaceutical (86)
Pharmacy benefit managers (27)
Phase I (22120)
Phase II (31041)
Phase III (23023)
Pipeline (2884)
Policy (266)
Postmarket research (2634)
Preclinical (9515)
Press Release (67)
Prostate cancer (201)
Psychedelics (50)
Radiopharmaceuticals (277)
Rare diseases (672)
Real estate (6141)
Recruiting (71)
Regulatory (24220)
Reports (51)
Research institute (2490)
Resumes & cover letters (386)
Rett syndrome (16)
RNA editing (15)
RSV (69)
Schizophrenia (134)
Series A (209)
Series B (158)
Service/supplier (11)
Sickle cell disease (84)
Special edition (25)
Spinal muscular atrophy (155)
Sponsored (37)
Startups (3822)
State (2)
Stomach cancer (15)
Supply chain (95)
Tariffs (83)
The Weekly (74)
Vaccines (957)
Venture capital (67)
Weight loss (359)
Women's health (58)
Worklife (18)
Date
Today (265)
Last 7 days (1048)
Last 30 days (3159)
Last 365 days (31672)
2025 (26807)
2024 (36387)
2023 (41112)
2022 (52404)
2021 (56922)
2020 (55180)
2019 (47818)
2018 (36043)
2017 (33302)
2016 (32699)
2015 (38753)
2014 (32493)
2013 (27415)
2012 (29483)
2011 (30159)
2010 (28267)
Location
Africa (784)
Alabama (78)
Alaska (7)
Arizona (282)
Arkansas (14)
Asia (40584)
Australia (6774)
California (9713)
Canada (2902)
China (908)
Colorado (403)
Connecticut (423)
Delaware (272)
Europe (89630)
Florida (1431)
Georgia (311)
Hawaii (2)
Idaho (61)
Illinois (747)
India (50)
Indiana (461)
Iowa (20)
Japan (330)
Kansas (123)
Kentucky (36)
Louisiana (20)
Maine (69)
Maryland (1262)
Massachusetts (7186)
Michigan (287)
Minnesota (559)
Mississippi (4)
Missouri (112)
Montana (31)
Nebraska (25)
Nevada (105)
New Hampshire (77)
New Jersey (2664)
New Mexico (30)
New York (2599)
North Carolina (1354)
North Dakota (9)
Northern California (4537)
Ohio (290)
Oklahoma (20)
Oregon (41)
Pennsylvania (2015)
Puerto Rico (19)
Rhode Island (45)
South America (1150)
South Carolina (50)
South Dakota (1)
Southern California (3720)
Tennessee (149)
Texas (1487)
United States (35184)
Utah (288)
Virginia (231)
Washington D.C. (78)
Washington State (813)
West Virginia (4)
Wisconsin (86)
Wyoming (2)
736,422 Results for "five prime therapeutics inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Prime Therapeutics supports FDA’s updated biosimilar recommendations
October 31, 2025
·
2 min read
Press Releases
Prime Therapeutics and Sempre Health Expand Innovative Behavior-Based Pricing Model to Advance Patient Affordability
October 31, 2025
·
3 min read
Rare diseases
Dyne Primed for Suitors Amid Novartis’ $12B Avidity Acquisition
The takeover of its competitor, announced Sunday, could also bring some attention to Dyne Therapeutics, which has a similar RNA-based pipeline in rare muscle diseases.
October 27, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Akebia Therapeutics Announces Five Presentations at ASN Kidney Week 2025
October 21, 2025
·
10 min read
Press Releases
Neurona Therapeutics Announces Priority Medicines (PRIME) Designation Granted by the European Medicines Agency (EMA) to NRTX-1001 in the Treatment of Drug-Resistant Focal Epilepsy
November 5, 2025
·
4 min read
Press Releases
Revelation Biosciences Inc. Completes Dosing of Patients in PRIME Study
July 17, 2025
·
6 min read
Press Releases
Prime Medicine to Host Virtual KOL Event to Showcase Wilson’s Disease Strategy
October 31, 2025
·
5 min read
Press Releases
Prime Medicine to Participate in Upcoming October 2025 Investor Conferences
October 8, 2025
·
2 min read
Press Releases
Prime Medicine Appoints Matthew Hawryluk, Ph.D., M.B.A. as Chief Business Officer
November 4, 2025
·
7 min read
Press Releases
Endeavor BioMedicines Receives Priority Medicines (PRIME) Designation from the European Medicines Agency for Taladegib (ENV-101) for the Treatment of Idiopathic Pulmonary Fibrosis
November 3, 2025
·
4 min read
1 of 73,643
Next
